ICUI
ICU Medical, Inc. Healthcare - Medical Instruments & Supplies Investor Relations →
ICU Medical, Inc. (ICUI) closed at $125.36 as of 2026-03-20, trading 12.7% below its 200-week moving average of $143.61. This places ICUI in the extreme value zone. The stock is currently moving closer to the line, down from -12.5% last week. The 14-week RSI sits at 38, indicating neutral momentum.
Trading volume is running at 1.7x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.84 ratio) is neutral — neither side is clearly dominating.
Over the past 1724 weeks of data, ICUI has crossed below its 200-week moving average 27 times. On average, these episodes lasted 21 weeks. Historically, investors who bought ICUI at the start of these episodes saw an average one-year return of +6.2%.
With a market cap of $3.1 billion, ICUI is a mid-cap stock. The company generates a free cash flow yield of 12.8%, which is notably high. The stock trades at 1.5x book value.
Share count has increased 2.9% over three years, indicating dilution.
Over the past 33.1 years, a hypothetical investment of $100 in ICUI would have grown to $1157, compared to $2609 for the S&P 500. ICUI has returned 7.7% annualized vs 10.4% for the index, underperforming the broader market over this period.
In the past 12 months, corporate insiders have made 2 open-market purchases totaling $2,626,073. Notably, these purchases occurred while ICUI is trading below its 200-week moving average — insiders are buying when the market is most pessimistic.
Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: ICUI vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After ICUI Crosses Below the Line?
Across 25 historical episodes, buying ICUI when it crossed below its 200-week moving average produced an average return of +6.6% after 12 months (median +4.0%), compared to +12.6% for the S&P 500 over the same periods. 60% of those episodes were profitable after one year. After 24 months, the average return was +22.0% vs +26.8% for the index.
Each line shows $100 invested at the moment ICUI crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
ICUI has crossed below its 200-week MA 27 times with an average 1-year return of +6.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jul 1994 | Oct 1994 | 13 | 8.6% | +35.6% | +1571.5% |
| Oct 1995 | Dec 1995 | 9 | 6.8% | -36.2% | +1435.0% |
| Jul 1996 | Dec 1997 | 77 | 48.5% | -33.7% | +1535.1% |
| Aug 1998 | Sep 1998 | 4 | 7.1% | +10.9% | +1389.4% |
| Oct 1999 | Oct 1999 | 3 | 11.5% | +108.1% | +1419.5% |
| Jul 2003 | Aug 2003 | 3 | 2.7% | +12.3% | +422.3% |
| Oct 2003 | Oct 2003 | 1 | 1.5% | N/A | +394.5% |
| Jul 2004 | Feb 2005 | 33 | 26.1% | +19.5% | +365.2% |
| Jun 2005 | Jun 2005 | 3 | 2.6% | +31.1% | +310.7% |
| Aug 2005 | Oct 2005 | 11 | 11.3% | +34.9% | +316.3% |
| Jul 2007 | Aug 2007 | 2 | 6.9% | -12.8% | +275.1% |
| Dec 2007 | Jan 2008 | 1 | 1.0% | -6.2% | +256.2% |
| Jan 2008 | Apr 2009 | 65 | 35.4% | +4.8% | +330.8% |
| May 2009 | May 2009 | 1 | 1.0% | -8.7% | +255.9% |
| Aug 2009 | Aug 2009 | 1 | 0.0% | -4.6% | +246.6% |
| Sep 2009 | Dec 2009 | 13 | 7.3% | +2.9% | +247.7% |
| Jan 2010 | Jul 2010 | 25 | 11.8% | +12.6% | +260.4% |
| Aug 2010 | Aug 2010 | 1 | 1.5% | +16.1% | +263.5% |
| Aug 2019 | Feb 2020 | 26 | 19.1% | +6.5% | -24.9% |
| Feb 2020 | Mar 2020 | 5 | 13.3% | +6.0% | -36.0% |
| May 2020 | Dec 2020 | 34 | 16.1% | +0.8% | -36.7% |
| Jan 2021 | Sep 2021 | 32 | 14.0% | +1.6% | -38.7% |
| Jan 2022 | Feb 2022 | 3 | 5.1% | -11.2% | -40.5% |
| Apr 2022 | Sep 2024 | 125 | 56.6% | -15.4% | -41.4% |
| Nov 2024 | Jan 2026 | 60 | 28.4% | -18.7% | -25.3% |
| Feb 2026 | Feb 2026 | 1 | 0.1% | N/A | -13.5% |
| Mar 2026 | Ongoing | 3+ | 12.7% | Ongoing | -5.0% |
| Average | 21 | — | +6.2% | — |
Frequently Asked Questions
Is ICUI below its 200-week moving average?
Yes. As of 2026-03-20, ICU Medical, Inc. (ICUI) is trading 12.7% below its 200-week moving average of $143.61. The current price is $125.36.
What is ICUI's 200-week moving average price?
ICU Medical, Inc.'s 200-week moving average is $143.61 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when ICUI drops below its 200-week moving average?
ICUI has crossed below its 200-week moving average 27 times in our data. On average, buying at that moment produced a one-year return of +6.2%. These dips have historically been decent entry points. These episodes lasted 21 weeks on average.
Is ICUI a good value right now?
Here's what our data says about ICUI as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 38. Free cash flow yield is 12.8%. Price-to-book is 1.5x. This is not a buy or sell recommendation — always do your own research.
How does ICUI compare to the S&P 500?
Over the past 33.1 years, $100 invested in ICUI would have grown to $1157, compared to $2609 for the S&P 500. That's 7.7% annualized vs 10.4% for the index. ICUI has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20